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Meta-Analysis of Potassium Intake and the Risk of Stroke
Marco Vinceti, MD, PhD; Tommaso Filippini, MD; Alessio Crippa, MS; Agnes de Sesmaisons, MS; Lauren A. Wise, ScD;
Nicola Orsini, PhD
Background-—The possibility that lifestyle factors such as diet, specifically potassium intake, may modify the risk of stroke has
been suggested by several observational cohort studies, including some recent reports. We performed a systematic review and
meta-analysis of existing studies and assessed the dose–response relation between potassium intake and stroke risk.
Methods and Results-—We reviewed the observational cohort studies addressing the relation between potassium intake, and
incidence or mortality of total stroke or stroke subtypes published through August 6, 2016. We carried out a meta-analysis of 16
cohort studies based on the relative risk (RR) of stroke comparing the highest versus lowest intake categories. We also plotted a
pooled dose–response curve of RR of stroke according to potassium intake. Analyses were performed with and without adjustment
for blood pressure. Relative to the lowest category of potassium intake, the highest category of potassium intake was associated
with a 13% reduced risk of stroke (RR=0.87, 95% CI 0.80–0.94) in the blood pressure–adjusted analysis. Summary RRs tended to
decrease when original estimates were unadjusted for blood pressure. Analysis for stroke subtypes yielded comparable results. In
the spline analysis, the pooled RR was lowest at 90 mmol of potassium daily intake (RRs=0.78, 95% CI 0.70–0.86) in blood
pressure–adjusted analysis, and 0.67 (95% CI 0.57–0.78) in unadjusted analysis.
Conclusions-—Overall, this dose–response meta-analysis confirms the inverse association between potassium intake and stroke
risk, with potassium intake of 90 mmol (3500 mg)/day associated with the lowest risk of stroke. ( J Am Heart Assoc. 2016;5:
e004210 doi: 10.1161/JAHA.116.004210)
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I n addition to the well-recognized determinants of strokesuch as hypertension, diabetes, and atrial fibrillation,
lifestyle risk factors such as diet, obesity, and smoking are
hypothesized to play a significant role in stroke etiology.1 The
identification of modifiable risk factors for stroke such as diet
quality is of key importance as potential targets for stroke
prevention strategies.1–4 Among the dietary factors that have
been associated with the risk of stroke, potassium has
received attention because of substantial evidence from
randomized controlled trials of a blood pressure–lowering
effect of potassium supplementation in hypertensive sub-
jects.5,6 Some, but not all, observational cohort studies have
found an inverse association between potassium intake and
stroke risk. This association, together with the effect of
potassium on blood pressure, have been considered when
setting dietary reference values and recommendations for this
nutrient.5,7–9
Since the latest reviews of the relation between potassium
and stroke risk,6,10,11 new cohort studies have been pub-
lished, all with observational design. We therefore undertook a
new meta-analysis including all relevant studies published to
date. Using a different method from previous meta-analyses,
we included studies based on dietary assessment methods as
well as on measurements of urinary potassium excretion. We
also aimed at exploring features of this association, such as
the presence and the shape of a dose–response relation, any
sex-related differences, and eventually blood pressure as a
potential mechanism mediating the association. Specific
associations between potassium intake and stroke subtypes
(ischemic versus hemorrhagic) were also investigated.
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Methods
We followed the “Preferred reporting items for systematic
reviews and meta-analyses” (PRISMA) statement for reporting
of this systematic review.12 We performed a systematic
literature search on potassium intake and stroke into the
PubMed/Medline database on August 6, 2016. The search
strategy is reported in Box 1 of Figure 1. “Stroke” and
“potassium” were used both as MeSH terms and title/
abstract keywords. Only cohort studies were selected,
provided that they investigated stroke incidence or stroke
mortality, and that they assessed dietary potassium intake
through dietary questionnaires or determination of urinary
potassium excretion. We did not apply any restriction based
on the length of follow-up. The extracted data (made in
duplicates by M.V. and T.F.) included the population
characteristics (sex, total study sample, location of the
study), the length of follow-up and the percentage loss at
follow-up, the baseline median/mean potassium intake for
each exposure category, the type of stroke and number of
cases for total stroke and stroke subtypes (including person-
years within each exposure category), the covariates
adjusted for in the multivariable analysis and eventually
the relative risk (RR) estimates with their 95% CI for all
exposure categories. We assessed the overall quality of
studies using the Newcastle-Ottawa quality assessment
scale13 in duplicate (T.F. and A.S.), and publication bias
through Egger’s test.14
In our meta-analyses, we used the RRs adjusted for the
greatest number of potential confounders in the first place
(“most adjusted model”). To assess the potential for overad-
justment when controlling for blood pressure, we also
computed alternative analyses based on most adjusted RRs
without adjustment for blood pressure level or hypertension
status (“blood pressure unadjusted model”). When the study
provided results by stroke subtype or by population subgroup
but no overall RR estimate, the individual RRs were used. In
addition, we performed analyses restricted to the studies that
reported results both with and without adjustment for blood
pressure.
We used random-effect models to account for heterogeneity
in study-specific results. We first included in this analysis the
RR and its 95% CI of the highest versus lowest categories of
potassium intake. When studies provided RR only for potas-
sium intake expressed as continuous variable, this value was
used. We always included in the meta-analyses overall
incidence data (ie, fatal and nonfatal stroke) except when only
mortality data for the study cohort were available. We
performed stratified analyses according to sex, stroke type
(ischemic versus hemorrhagic) and outcome (fatal and nonfatal
versus fatal only), method of assessment of potassium intake
(dietary questionnaires versus urinary excretion), and category
of baseline potassium intake. For the latter analysis, we
defined 3 exposure subgroups using dietary potassium intakes
of 90 and 120 mmol/day as cut points, similar to those
previously used to investigate the relation of potassium with
blood pressure6 and stroke15 and also corresponding to
proposed dietary reference intakes of this mineral.5,7 A study
could contribute to this analysis more than once, when its
intake categories fell into more than 1 of the defined
subgroups. When several intake categories fell in the same
subgroup, we used the RR related to the highest category. In
cases where the baseline potassium exposure assessment
was expressed as 24-hour urinary potassium excretion, we
multiplied that value by 1.3 to convert it to daily dietary
intake.15–17
We also performed a dose–response meta-analysis to
assess a potential nonlinear relation between potassium
intake and stroke risk, using the methodology developed by
Greenland and Longnecker, and Orsini et al.18,19 Restricted
cubic spline models with 3 knots were fitted in each study
taking into account the covariance among log RR, and the
regression coefficients were then combined using multivariate
meta-analysis. For each potassium category, we assigned the
mean intake (or median if mean was not available), along with
RR with its 95% lower and upper bounds, the number of cases,
and amount of person-years. If neither means nor medians
were available, we used the midpoint within each exposure
category. For open (highest and lowest) categories for which
no mean or median value was provided by the authors, we
entered a 20% higher or lower value departing from the
closest cut point, based on what was observed in studies with
complete data.20–23 We excluded from analysis the studies
not reporting the number of subjects and/or the person-years
of follow-up in each intake category, to avoid biases in the
estimates for the variances.19 Studies that provided a RR
analyzed as a continuous variable were also excluded from
this dose–response analysis. In stratified analysis, we
assessed the dose–response according to stroke subtype.
We finally carried out several sensitivity analyses by including
studies with missing category-specific number of cases and
person-year, by excluding the 2 studies based on single unit
increase,24,25 by using a shift of 10% instead of 20% to assign
the typical potassium intake for the highest and lowest
exposure categories, by excluding studies based on urinary
potassium excretion measurement, by considering a lower
multiplication factor (1.16) based on data from the Trial of
Nonpharmacologic Intervention in the Elderly (TONE)26 to
estimate dietary potassium intake from urinary excretion
measurement, and eventually by removing the studies that
reported fatal stroke only.
We used the metan, glst, mkspline, and mvmeta routines in
the Stata statistical software (version 14.1, 2016; Stata Corp,
College Station, TX).
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Results
In the first-stage search, we identified 446 potentially eligible
studies, of which 430 were subsequently excluded on the
basis of title/abstract or after full-text reading when abstracts
were not available in PubMed. Three studies were further
identified with backward and forward citations method
(“snowballing” method). Among the 19 studies reviewed, 3
were excluded: 227,28 because more recent results for the
446 studies screened
 16 studies identified
Studies 
excluded
Main reasons for exclusion 
241 not related to K intake or cerebral stroke 
83 about medication effects  
40 biochemical studies 
14 genetic studies 
6 animal experiments
44 commentaries or literature reviews 
1 cross-sectional study 
1 case-control study 
2 studies excluded as more recent results 
for the same cohorts were available
1 study reporting stroke mortality was 
excluded from main analysis as result on 
incidence was reported in another paper
19 studies reviewed 
16 studies included in 
the meta-analysis 
Studies Search strategy
1171 (potassium[MeSH Term] OR potassium[tiab]) AND 
(stroke[MeSH Term] OR stroke [tiab])
599 (potassium[MeSH Term] OR potassium[tiab]) AND 
Term]
965 (potassium[MeSH Term] OR potassium[tiab]) AND 
(stroke[MeSH Term] OR stroke[tiab]) NOT 
("review"[Publication Type])  
418 (potassium[MeSH Term] OR potassium[tiab]) AND 
446 (("potassium, dietary"[MeSH Terms] OR "potassium"[MeSH 
Terms]) OR potassium[tiab] OR "hypokalemia"[MeSH Terms] 
OR "hyperkalemia"[MeSH Terms]) AND ("stroke"[MeSH 
Terms] OR stroke[tiab]) AND "humans"[MeSH] NOT 
"review"[Publication Type] 
Box 1
Figure 1. Flow chart summarizing study identification and selection. Box 1 shows details of
research strategy.
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same cohorts were available29,30 and 1 because it reported on
stroke mortality31 in a cohort for which overall incidence data
were subsequently reported20 (yet this article was included in
the subgroup analysis for stroke mortality). Thus, a final
number of 16 studies published between 1987 and 2016
were available for overall analyses (Figure 1).20–25,29,30,32–39
These studies involved 19 522 stroke events among 639 440
participants (full details are reported in Table S1). Six studies
were conducted in the United States,20,25,29,30,33,38 5 in
Europe,23,24,34,37,39 3 in Asia,32,35,36 and 2 large cohorts with
subjects recruited from several countries.21,22 All studies
used internal comparison groups. Fourteen studies reported
comparison between intake categories,20–23,29,30,32–39 2
reported RR by continuous increase of potassium intake,24,25
and 2 reported both continuous and categorical RR.23,39 In
studies reporting comparison between potassium intake
categories with blood pressure–adjusted RR estimates,
median intake was 103.0 mmol/day (range 68–149.8) in
the highest category and 50.1 mmol/day (24–100.1) in the
lowest one, while corresponding figures for studies reporting
blood pressure–unadjusted estimates were 103.0 mmol/day
(60–149.8) and 52.5 mmol/day (24–100.1). Nine studies
assessed potassium intake through food frequency question-
naires,24,29,30,33,34,36–39 4 using structured dietary recall
administered by a dietitian,20,25,32,35 and 4 measured urinary
potassium excretion by using either an overnight urine
sample,24 a single morning fasting urine collection,21,22 or
multiple 24-hour urine collection.23 Most studies involved
subjects without personal history of stroke at baseline, with
some apparent exceptions.21,22,39 Outcome was ascertained
by an independent blind assessment or by record linkage in 2
and 9 studies, respectively, while it was self-reported in 4
studies. Median follow-up was >10 years in 12 of the studies,
ranging from 3.7 to 25.8 years. Only 10 studies reported a
follow-up not lower than 95% of the cohort. All studies
controlled for age and all but 2 adjusted for smoking
status.32,33 Seven and 5 studies, respectively, included the
adjustment for history of hypertension21,29,30,35–38 or for
various types of blood pressure measurements20,21,25,33,34 in
1 regression model. Other covariates frequently considered
were body mass index20–24,29,30,35–39 or presence of obe-
sity,25,36 level of physical activity,20,21,29,30,34–39 total energy
intake,20,24,34,37,39 serum cholesterol level* and/or choles-
terol intake,20,37 saturated fat intake,20,24 and alcohol
intake.20,22–24,29,30,34–39
Overall quality of studies is reported in Table S2. Newcastle-
Ottawa scale score ranged from 4 to 9, with a median value of
7. No substantial evidence of publication bias emerged from
the funnel plot (Figure 2), as also confirmed by the Egger
asymmetry test, whose intercept based on all retrieved studies
was 0.32 (95% CI 1.82 to 1.19, P=0.663).
Forest plots of the meta-analysis using adjusted RR
estimates comparing the highest versus the lowest potassium
category, either including blood pressure level or hypertension
status among the covariates or not, are reported in
Figure 3.20–25,29,30,32–39 Heterogeneity, expressed as I2, was
45.5% in the “most adjusted model” and 53.2% in the “blood
pressure–unadjusted model.” The pooled RR for stroke was
0.87 (95% CI 0.80–0.94) in the “most adjusted model,” while
this estimate was slightly lower (0.85, 95% CI 0.79–0.91)
when estimates were not adjusted for blood pressure.
Restricting the meta-analysis to studies that provided RRs
both with and without adjustment for blood pressure, the
difference between pooled estimates was further increased,
with summary RR of 0.90 (95% CI 0.84–0.96) in the adjusted
analysis and 0.85 (95% CI 0.79–0.92) in the unadjusted one.
In stratified analyses by subgroups of dietary potassium
intake (<90, 90–120, and ≥120 mmol/day), the summary
RRs for the highest versus the lowest potassium exposure
category increased with increasing exposure, as did the
statistical imprecision of the estimate: 0.87 (95% CI 0.82–
0.93), 0.92 (95% CI 0.82–1.04), and 1.02 (95% CI 0.83–1.24)
for the respective subgroups (Figure 4).20–23,29,30,32–39 Cor-
responding figures for “blood pressure–unadjusted model”
were 0.85 (95% CI 0.81–0.89), 0.90 (95% CI 0.79–1.01), and
0.97 (95% CI 0.77–1.21). In the analysis restricted to studies
reporting estimates both with and without adjustment for
blood pressure (Figure S1), the blood pressure–adjusted
estimates were higher in all exposure categories compared to
the unadjusted ones. Comparing adjusted with unadjusted
estimates, overall RRs decreased from 0.88 (95% CI 0.82–
0.95) to 0.85 (95% CI 0.80–0.90) in the lowest subgroup of
potassium intake, from 0.85 (95% CI 0.82–0.95) to 0.78 (95%
0
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Funnel plot with pseudo 95% confidence limits
Figure 2. Funnel plot for publication bias for the observational
cohort studies included in the meta-analysis. Long-dash line shows
fitted line corresponding to the regression test for funnel-plot
asymmetry proposed by Egger.
*References 20, 21, 23, 25, 29, 30, 34, 36–38.
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CI 0.61–0.99) in the intermediate subgroup of potassium
intake, and from 0.96 (95% CI 0.80–1.14) to 0.90 (95% CI
0.74–1.09) in the highest subgroup of potassium intake.
In stratified analysis by outcome definition, a considerably
lower summary RR estimate was found for fatal stroke than
for overall stroke incidence, though the RR was based on only
4 studies (Figure S2).25,31,32,35 When stratifying by stroke
subtype, summary RRs were 0.87 (95% CI 0.81–0.94) for
ischemic stroke (7 studies) and 0.93 (95% CI 0.81–1.07) for
hemorrhagic stroke (7 studies) for the “most adjusted model”
(Figure 5).29,30,32,34,35,37,38 The use of the “blood pressure–
unadjusted model” had little effect on the estimate for
Overall  (I−squared = 45.5%, p = 0.017)
Larsson 2011
Green 2002 (2)
Adebamowo 2015b
O’Donnel 2011
Sluijs 2014
Larsson 2008 (2)
Larsson 2008 (3)
Seth 2014
Kieneker 2016
Khaw 1987
Umesawa 2008
Bazzano 2001
Reference
Geleijnse 2007
Adebamowo 2015a
Green 2002 (1)
O’Donnell 2014
Lee 1988
Weng 2008
Larsson 2008 (1)
0.87 (0.80, 0.94)
0.89 (0.72, 1.10)
1.15 (0.71, 1.85)
0.93 (0.75, 1.15)
0.68 (0.49, 0.92)
0.95 (0.68, 1.33)
0.87 (0.62, 1.21)
1.35 (0.86, 2.11)
0.88 (0.79, 0.98)
1.33 (0.79, 1.87)
0.60 (0.44, 0.82)
0.83 (0.60, 1.14)
0.76 (0.58, 1.01)
RR (95% CI)
1.17 (0.86, 1.58)
0.91 (0.78, 1.06)
0.57 (0.39, 0.83)
0.97 (0.72, 1.31)
0.72 (0.53, 0.99)
0.59 (0.39, 0.89)
0.92 (0.81, 1.04)
100.00
7.10
2.37
7.04
4.47
4.10
4.12
2.64
11.08
2.82
4.55
4.36
5.27
Weight
4.69
9.23
%
3.45
4.79
4.52
3.02
10.38
1.5 2
A
Overall  (I−squared = 53.2%, p = 0.006)
Bazzano 2001
Adebamowo 2015a
Kieneker 2016
Adebamowo 2015b
Reference
Lee 1988
Larsson 2008 (3)
Larsson 2008 (1)
Geleijnse 2007
O’Donnell 2014
O’Donnel 2011
Umesawa 2008
Larsson 2011
Sluijs 2014
Seth 2014
Larsson 2008 (2)
Khaw 1987
0.85 (0.79, 0.91)
0.76 (0.60, 0.97)
0.83 (0.75, 0.93)
1.33 (0.79, 1.87)
0.88 (0.75, 1.03)
RR (95% CI)
0.72 (0.53, 0.99)
1.25 (0.82, 1.92)
0.87 (0.77, 0.98)
1.09 (0.87, 1.36)
0.97 (0.72, 1.31)
0.55 (0.42, 0.73)
0.77 (0.63, 0.94)
0.90 (0.78, 1.05)
0.95 (0.68, 1.33)
0.87 (0.79, 0.96)
0.77 (0.56, 1.06)
0.60 (0.44, 0.82)
100.00
5.80
10.95
2.52
8.68
Weight
4.12
2.57
10.35
6.30
%
4.38
4.87
7.07
9.10
3.72
11.40
4.00
4.15
1.5 2
B
.
.
blood pressure−adjusted
Bazzano 2001
Geleijnse 2007
Larsson 2008 (1)
Larsson 2008 (2)
Larsson 2008 (3)
Umesawa 2008
Larsson 2011
O’Donnel 2011
Seth 2014
Adebamowo 2015a
Adebamowo 2015b
Subtotal  (I−squared = 10.3%, p = 0.346)
blood pressure−unadjusted
Bazzano 2001
Geleijnse 2007
Larsson 2008 (1)
Larsson 2008 (2)
Larsson 2008 (3)
Umesawa 2008
Larsson 2011
O’Donnel 2011
Seth 2014
Adebamowo 2015a
Adebamowo 2015b
Subtotal  (I−squared = 52.1%, p = 0.022)
Reference
0.76 (0.58, 1.01)
1.17 (0.86, 1.58)
0.92 (0.81, 1.04)
0.87 (0.62, 1.21)
1.35 (0.86, 2.11)
0.83 (0.60, 1.14)
0.89 (0.72, 1.10)
0.68 (0.49, 0.92)
0.88 (0.79, 0.98)
0.91 (0.78, 1.06)
0.93 (0.75, 1.15)
0.90 (0.84, 0.96)
0.76 (0.60, 0.97)
1.09 (0.87, 1.36)
0.87 (0.77, 0.98)
0.77 (0.56, 1.06)
1.25 (0.82, 1.92)
0.77 (0.63, 0.94)
0.90 (0.78, 1.05)
0.55 (0.42, 0.73)
0.87 (0.79, 0.96)
0.83 (0.75, 0.93)
0.88 (0.75, 1.03)
0.85 (0.79, 0.92)
RR (95% CI)
5.09
4.27
20.43
3.56
2.01
3.86
8.37
4.00
25.45
14.71
8.24
100.00
6.71
7.37
13.32
4.45
2.78
8.42
11.36
5.52
15.05
14.29
10.72
100.00
Weight
%
1.5 2
C
Figure 3. Meta-analysis of the relative risk (RR), with 95% CI of
stroke in observational cohort studies, according to the covariates
included in multivariate modeling. RRs from all studies using the
“most adjusted model” (A) and the “blood pressure–unadjusted
model” (B), and from the studies reporting both blood pressure–
adjusted and unadjusted estimates (C).
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<90 mmol/day
Lee 1988
Bazzano 2001
Green 2002 (1)
Green 2002 (2)
Umesawa 2008
Weng 2008
Larsson 2011
O’Donnell 2014
Seth 2014
Sluijs 2014
Adebamowo 2015a
Adebamowo 2015b
Kieneker 2016
Subtotal  (I−squared = 7.3%, p = 0.373)
90−120 mmol/day
Bazzano 2001
Green 2002 (1)
Green 2002 (2)
Larsson 2008 (1)
Larsson 2008 (2)
Larsson 2008 (3)
Larsson 2011
O’Donnel 2011
O’Donnell 2014
Sluijs 2014
Adebamowo 2015b
Kieneker 2016
Subtotal  (I−squared = 53.9%, p = 0.013)
≥120 mmol/day
Larsson 2008 (1)
Larsson 2008 (2)
Larsson 2008 (3)
Kieneker 2016
Subtotal  (I−squared = 42.2%, p = 0.158)
Reference
0.72 (0.53, 0.99)
0.85 (0.71, 1.01)
0.78 (0.39, 1.17)
1.25 (0.79, 1.71)
0.83 (0.60, 1.14)
0.59 (0.39, 0.89)
0.85 (0.71, 1.03)
0.85 (0.70, 1.03)
0.88 (0.79, 0.98)
0.82 (0.65, 1.03)
0.91 (0.78, 1.06)
0.91 (0.75, 1.09)
1.32 (0.85, 2.04)
0.87 (0.82, 0.93)
0.76 (0.58, 1.01)
0.57 (0.39, 0.83)
1.15 (0.71, 1.85)
1.07 (0.96, 1.21)
0.96 (0.70, 1.31)
0.98 (0.62, 1.56)
0.89 (0.72, 1.10)
0.68 (0.49, 0.92)
0.97 (0.72, 1.31)
0.95 (0.68, 1.33)
0.93 (0.75, 1.15)
1.41 (0.94, 1.88)
0.92 (0.82, 1.04)
0.92 (0.81, 1.04)
0.87 (0.62, 1.21)
1.35 (0.86, 2.11)
1.33 (0.79, 1.87)
1.02 (0.83, 1.24)
RR (95% CI)
3.72
10.86
1.23
2.47
3.53
2.17
9.85
9.21
24.73
6.65
13.88
9.77
1.93
100.00
8.92
6.30
4.54
14.93
7.86
4.79
11.19
7.81
8.26
7.28
11.12
7.00
100.00
47.60
22.06
14.71
15.63
100.00
Weight
%
1.5 2
A
.
.
.
<90 mmol/day
Lee 1988
Bazzano 2001
Umesawa 2008
Larsson 2011
O’Donnell 2014
Seth 2014
Sluijs 2014
Adebamowo 2015a
Adebamowo 2015b
Kieneker 2016
Subtotal  (I−squared = 0.0%, p = 0.688)
90−120 mmol/day
Bazzano 2001
Larsson 2008 (1)
Larsson 2008 (2)
Larsson 2008 (3)
Larsson 2011
O’Donnel 2011
O’Donnell 2014
Sluijs 2014
Adebamowo 2015b
Kieneker 2016
Subtotal  (I−squared = 63.3%, p = 0.004)
≥120 mmol/day
Larsson 2008 (1)
Larsson 2008 (2)
Larsson 2008 (3)
Kieneker 2016
Subtotal  (I−squared = 55.0%, p = 0.083)
Reference
0.72 (0.53, 0.99)
0.84 (0.72, 0.99)
0.77 (0.63, 0.94)
0.86 (0.74, 0.99)
0.85 (0.70, 1.03)
0.87 (0.79, 0.96)
0.82 (0.65, 1.03)
0.83 (0.75, 0.93)
0.87 (0.74, 1.03)
1.32 (0.85, 2.04)
0.85 (0.81, 0.89)
0.76 (0.60, 0.97)
1.01 (0.90, 1.14)
0.90 (0.66, 1.23)
0.95 (0.60, 1.50)
0.90 (0.78, 1.05)
0.55 (0.42, 0.73)
0.97 (0.72, 1.31)
0.95 (0.68, 1.33)
0.88 (0.75, 1.03)
1.41 (0.94, 1.88)
0.90 (0.79, 1.01)
0.87 (0.77, 0.98)
0.77 (0.56, 1.06)
1.25 (0.82, 1.92)
1.33 (0.79, 1.87)
0.97 (0.77, 1.21)
RR (95% CI)
2.55
9.83
6.23
11.77
6.68
26.25
4.71
21.55
9.12
1.30
100.00
10.56
15.37
8.25
5.06
14.17
9.32
8.60
7.59
13.77
7.30
100.00
41.53
24.01
17.37
17.09
100.00
Weight
%
1.5 2
B
Figure 4. Meta-analysis of the relative risk (RR), with 95% CI of
stroke in observational cohort studies according to category of
baseline dietary potassium intake (<90, ≥90 to <120, ≥120 mmol/
day). Estimates are from the most-adjusted multivariate models
with (A) and without (B) adjustment for blood pressure.
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ischemic stroke, while the summary RR for hemorrhagic
stroke was lower (0.85, 95% CI 0.75–0.95). By conducting
separate analyses according to potassium intake assessment
methods, summary RRs obtained when pooling studies based
on urinary assessment methods (4 studies) were higher and
more statistically unstable (wider confidence intervals) than
when pooling studies based on dietary questionnaires (12
studies), both when the “most adjusted models” and “blood
pressure–unadjusted models” were applied (data not shown).
In sex-specific analyses, summary RRs for stroke were
similar for males and females in both the “most adjusted
models” and “blood pressure–unadjusted models.” Values
obtained with the blood pressure–unadjusted models tended
to be lower than those from the most adjusted models for
both sexes (Figure S3). This tendency was enhanced when the
analysis was restricted to studies providing both RRs with and
without blood pressure adjustment.
In spline regression analysis (Figure 6A), we observed a
decrease in the pooled RR up to around 90 mmol/day
potassium intake (3500 mg/day), based on the most
adjusted model. At this cut point of intake, the RR was 0.78
(95% CI 0.70–0.86), while above it the RR flattened and if any
slightly increased above 130 mmol/day, though there was
substantial uncertainty in this upper range of the distribution.
Based on RRs not adjusted for blood pressure, a U-shaped
dose–response curve was observed (Figure 6B). Similarly,
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Figure 5. Meta-analysis of the relative risk (RR) with 95% CI of
stroke in observational cohort studies according to stroke
subtype (ischemic and hemorrhagic). Estimates are from the
“most adjusted model” (A) and from the “blood pressure–
unadjusted model” (B).
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Figure 6. Pooled dose–response association between potas-
sium intake and risk of stroke (solid line) in a meta-analysis
modeling potassium intake with restricted cubic splines in a
multivariate random-effects model, with (A) and without (B)
adjustment for blood pressure. The relative risks are plotted on
the log scale, with 25 mmol of daily potassium intake serving as
referent category. Dashed lines represent the 95% CI for the
spline model.
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pooled RR for stroke decreased up to a potassium intake of
around 90 mmol/day (RR 0.67, 95% CI 0.57–0.78). However,
the trend was reversed above this cut point. In stratified
analysis according to stroke subtype, based on considerably
fewer cases, a linear dose–response relation was confirmed
up to around 90 mmol/day of potassium intake, while little
evidence of an increased risk at higher levels of intake
emerged in both the BP-adjusted and unadjusted analyses
(Figure S4). Finally, the various sensitivity analyses we
performed on this dose–response relation had little effect
on the results (data not shown).
Discussion
As compared with the latest meta-analyses of prospective
cohort studies on potassium intake and stroke risk,6,10,11 the
present systematic review includes 5 recently published
studies22,23,29,30,38 and an older eligible study that had
previously gone undetected.32 We also explored the dose–
response relation between potassium intake and stroke risk
by stratifying results into 3 subgroups of potassium intake
and updating a previously performed spline regression
analysis.10 A dilution of the effect by overadjustment for
blood pressure, the role of sex as a potential effect-modifier,
and a possible differential effect of potassium intake on
stroke subtypes was also investigated. A preliminary assess-
ment showed little evidence for publication bias, thus not
supporting the occurrence of this potential source of bias.
Overall, the summary estimates computed in the present
meta-analysis confirm the previously observed inverse asso-
ciation between potassium intake and risk of stroke, though
our summary RRs were slightly closer to the unity than those
computed in the World Health Organization report15 and the
D’Elia et al review,11 but on the converse they had higher
precision. In addition, we found evidence that the association
may not be linear, and that potassium intake of 90 mmol
(3500 mg) per day may be associated with the lowest risk
of stroke.
Summary RRs were generally lower when we used
estimates unadjusted for blood pressure compared with
adjusted estimates. This difference was enhanced when we
restricted our analyses to the studies that provided RRs both
with and without adjustment for blood pressure in addition to
other variables. This may suggest that at least part of a
beneficial effect of potassium on stroke risk is mediated by a
beneficial effect on blood pressure,15 and therefore the risk
for overadjustment when blood pressure is included among
the covariates in multivariate analysis. Still, the inverse
association between potassium intake and stroke risk
remained when estimates were adjusted for blood pressure,
consistent with the hypothesis of an involvement of other
mechanisms, such as a protective effect of potassium against
thrombus formation, atherosclerotic lesion progression,
endothelial dysfunction, and free radical generation.29,40–43
Blood pressure may also be an effect modifier of the
potassium–stroke relation, although results of the 2 studies
that investigated this issue are entirely contradictory.37,38
However, it must be noted that blood pressure was assessed
at baseline, and generally with a single clinic measurement or
a simple assessment of hypertensive status, thus precluding
the possibility of taking into account variations of blood
pressure during the follow-up and their possible role in
modifying stroke risk. In addition, the multivariate regression
models including blood pressure might not be entirely
comparable with the blood pressure–unadjusted ones, since
in the various studies other covariates, in addition to blood
pressure, were considered in the “most adjusted analysis.”
Therefore, our indication for a blood pressure–independent
effect of potassium intake on stroke risk must be interpreted
with caution.
We found evidence of a dose–response relation between
potassium intake and stroke risk, both in stratified analysis
and in spline regression analysis. Forest plots were consistent
with a protective effect of potassium intake in the lowest
(<90 mmol/day) and intermediate categories (90–
120 mmol/day) of baseline daily potassium intake, but not
in the highest subgroup. The spline analysis allowed us to
better model the shape of the dose–response relation
between potassium intake and stroke risk. This analysis
indicated a decrease of RRs for daily potassium intake from
around 40 mmol up to 90 mmol, above which the curve
tended to remain stable. When RRs unadjusted for blood
pressure were used in the model, a U-shaped dose–response
was observed, although the RRs estimates had very large
confidence intervals at high levels of potassium intakes, and
the increase at higher levels of potassium intake was not
observed in the analysis by stroke subtypes (based on fewer
number of cases compared with total stroke). Therefore, the
possibility that high intakes of potassium may have detrimen-
tal effects on stroke risk cannot be entirely ruled out, also in
line with recent observation on hypertension risk.44 Overall,
these results suggest that a potassium intake on the order of
90 mmol/day may be adequate for stroke prevention. This
supports the guidelines for a minimum adequate potassium
intake in adults and children of 90 mmol/day issued by the
World Health Organization,5 and the dietary reference values
of 90 mmol/day for adults proposed by the European Food
Safety Authority.9
We did not identify sex-related differences concerning the
potassium–stroke association using blood pressure–adjusted
estimates, while analyses based on blood pressure–unad-
justed RRs suggested an increased protective effect of
potassium in males. We could not explore potential effects
of ethnic or genetic factors due to the lack of data collected
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from these studies. We found a lower summary RR for
ischemic stroke than for hemorrhagic stroke when based on
the “most adjusted model.” However, estimates for hemor-
rhagic stroke were more statistically imprecise, due to a
greater inconsistency among studies estimates and to the
lower number of cases recorded for this outcome, as
expected. Interestingly, adjustment for blood pressure
appeared to affect mainly the hemorrhagic subtype. This is
consistent with the hypothesis of an effect of potassium
mediated by its hypotensive effect, as hemorrhagic stroke is
more strongly associated with raised blood pressure than
ischemic stroke.45 Overall, taking into account a potential
overadjustment for blood pressure in the “most adjusted
model,” the effect of potassium on both stroke subtypes
appears to be similar, though possibly mediated by partially
different mechanisms.
A limitation of the evidence yielded by the present meta-
analysis is that it generates from studies with observational
and not experimental design, thus potentially subject to
biases due to (nondifferential) exposure misclassification or to
unmeasured confounding.
The first issue affects particularly studies that relied on the
less-reliable methods to assess potassium intake, such as
those based on concentration in spot urine samples, and is
expected to lead to a dilution of the RR estimates towards the
unity. In the present analysis, and contrary to the previous
analysis by Larsson et al,10 we have included studies that
used potassium urinary excretion as a marker of potassium
intake. This allowed the inclusion of a significantly higher
number of cases and of populations with rather “high”
potassium intake,22,23 thus allowing a better and more
statistically stable assessment of the risk of stroke in the
higher range of potassium intake, as compared with the
previous meta-analysis.10 Yet, out of the 4 studies that
measured potassium urinary excretion, only 1 collected
multiple 24-hour urine samples,23 while the others used
cruder methods (overnight urine collection24 and morning
sport urine collection),21,22 which are more prone to exposure
misclassification.46 In addition, there are uncertainties over
the multiplication factor to be used to estimate potassium
intake from potassium urinary excretion. Still, exclusion of
these 4 studies or use of an alternative factor did not
appreciably change the results of both the meta-analysis and
the pooled dose–response analysis.
The second concern is of greater importance for study
validity and was outlined as a major methodological limitation
in most studies. In fact, a certain degree of collinearity
between minerals and more generally nutrient intakes has
been reported,29,30 and no observational study could clearly
assess all the remaining dietary variables and other potential
confounders. This is a major difference with the literature
linking potassium intake and blood pressure, in which a large
number of intervention studies are available, particularly in
hypertensives,6,47 in addition to a few observational cohort
studies.48,49
In conclusion, despite the limitations of observational
studies and of pooling results from studies carried out in
different populations, with some differences in design and
data analysis, our meta-analysis indicates an inverse associ-
ation between potassium intake and risk of total, hemor-
rhagic, and ischemic stroke, with the lowest risk occurring at
a potassium intake of around 90 mmol/day. The mechanisms
by which potassium intake may affect stroke risk require
further investigation, as it can only partially be explained by an
effect on blood pressure, particularly for ischemic stroke and
in females.
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Table S1. Number of participants, number of events, years of follow-up and adjustment factors of included studies (SBP, systolic blood 
pressure; BP, blood pressure; BMI, body mass index; LDL, low density lipoprotein; HDL, high density lipoprotein). 
	
Reference Total subjects 
N° 
events 
Years of 
follow-up 
Age at 
enrolment 
Complete 
follow-up* 
Potassium 
assessment† 
Highest to 
lowest category‡ Adjustment factors 
Khaw 
19871 859 24 12 50-79 99.8 Dietary recall 10 units increase 
Age, SBP, cholesterol levels, obesity, smoking, fasting glucose 
level and estrogen use 
Lee 
19882 7591 408 16 46-65 94.8 Dietary recall >71.0 to <37.6 Age 
Bazzano 
20013 9805 927 19 25-74 96.1 Dietary recall >68.4 to <34.6 
1: age, race, sex and energy intake 
2: 1+ SBP, serum cholesterol, BMI, history of diabetes, 
physical activity, education level, regular alcohol consumption, 
current smoking, vitamin suppl. use, intake of saturated fat 
intake, cholesterol, sodium, calcium, fiber, Vitamin C and 
Vitamin A 
Green 
20024 5600 473 7.3 65+ 98.0 FFQ ≥106.6 to ≤59.8 age, sex, history of diabetes, coronary artery disease, congestive heart failure, atrial fibrillation, SBP, serum creatinine, serum K, potassium supplement use. 
Gelejinse 
20075 5531 181 5.5 55+ No data 
FFQ and urinary 
potassium 
excretion 
(overnight 
collection) 
1 SD increase 
1: age, sex and 24h urinary creatinine excretion 
2: 1+ BMI, smoking status, diabetes, use of diuretics, highest 
completed education 
3: 2+ daily intake of total energy, alcohol, calcium, saturated fat 
and 24-h urinary Na excretion 
Larsson 
20086 26556 3381 13.6 50-69 100 FFQ >149.8 to <100.0 
1: age and supplementation group 
2: 1+ number of cigarettes smoked daily, SBP and DBP, serum 
total cholesterol, serum HDL, history of diabetes and coronary 
heart disease, leisure-time for physical activity, alcohol and 
total energy intake 
Umesawa 
20087 58730 986 12.7 40-79 95.8 Dietary recall >68 to <35 
1: age and sex 
2: 1+ BMI, smoking status, alcohol intake, history of 
hypertension, history of diabetes, menopause, hormone 
replacement therapy, time spent on sport activity, walking time, 
educational status, perceived mental stress and calcium intake 
3: 2 + sodium intake 
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Weng 
20088 1772 132 10.6 40+ 99.4 FFQ >80.6 to <65.3 
1: age, sex and sex*age interaction 
2: 1+ hypertension, use of antihypertensive drugs, diabetes 
mellitus, study area, central obesity, alcohol consumption 
habits, smoking habits, sex-smoking interaction, BMI, self 
report heart disease, hypercholesterolemia, 
hypertriglyceridemia, physical activity, fibrinogen, apoliprotein 
B and plasminogen 
Larsson 
20119 34670 1680 10.4 49-83 100 FFQ >95.8 to <61.9 
1: age 
2: age, smoking status, pack-years of smoking, educational 
level, BMI, total physical activity level, history of diabetes 
history of hypertension, aspirin use, family history of 
myocardial infarction, intake of total energy, alcohol, protein, 
cholesterol, total fiber and folate 
O’Donnell 
201110 28880 1282 4.7 55+ 98.8 
Urinary potassium 
excretion (spot 
morning collection) 
>76.7 to <38.4 
1: crude 
2: age, sex, ethnicity, prior history of stroke or myocardial 
infarction, creatinine, BMI, co-morbid vascular risk factors 
(hypertension, diabetes mellitus, atrial fibrillation, smoking, 
LDL and HDL), treatment allocation, and treatment with 
statins, β-blockers, diuretic therapy, calcium antagonist, and 
anti-thrombotic therapy, fruit and vegetable consumption, level 
of exercise, baseline BP and change in SBP from baseline to 
last follow-up, and urinary sodium. 
O’Donnell 
201411 101887 872 3.7 35-70 95.0 
Urinary potassium 
excretion (spot 
morning collection) 
>76.7 to <38.4 
1: crude 
2: age, sex, educational level, ancestry (Asian vs. non-Asian), 
alcohol intake, BMI, diabetes mellitus, history of 
cardiovascular events, and current smoking.  
Seth 
201412 90137 3046 11.1 50-79 100 FFQ ≥81.7 to <49.2 
1: crude 
2: age, race, hypertension status 
3: 2+ smoking status, physical activity, history of diabetes 
mellitus, history of atrial fibrillation, history of myocardial 
infarction, hormone use, alcohol intake, aspirin use, high 
cholesterol, BMI 
Slujis 
201413 36094 631 12 21-70 No data FFQ ≥107.0 to ≤78.2 
1: age and sex 
2: 1+ BMI, education, physical activity, smoking status, intake 
of alcohol, total energy intake and calcium intake 
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Adebamowo 
2015a14 180864 3780 25.8 25-55 90.9 FFQ ≥87.6 to <58.3 
1: age 
2: age, calendar year, total calories, BMI, parental history of 
heart disease, alcohol intake, physical activity, smoking, 
postmenopausal hormone therapy, oral contraceptive use, 
menopausal status, aspirin, multivitamin, history of 
hypertension, hypercholesterolemia, diabetes at baseline, 
thiazide use. 
3: 2+ calcium intake 
Adebamowo 
2015b15 42669 1547 24 40-75 82.9 FFQ >107.9 to <68.8 
1: age 
2: age, calendar year, total calories, smoking, BMI, parental 
history of heart disease, alcohol intake, physical activity, 
aspirin, multivitamin, history of hypertension, 
hypercholesterolemia, diabetes at baseline, and thiazide.  
3: 2+ dietary and supplemental intakes of magnesium, 
potassium, and calcium. 
Kieneker 
201616 7795 172 10.5 28-75 81.0 
Urinary potassium 
excretion  
(multiple 24-hour 
collection) 
>130 to <59.8 
1: age and sex 
2: 1+ lifestyle and dietary factors (BMI, smoking, alcohol 
consumption, education and 24h urinary sodium) 
3: 2+ additional cardiovascular risk factors including parental 
history of cardiovascular disease,, use of lipid-lowering drugs, 
presence of type-2 diabetes, total to HDL, cholesterol ratio, 
urinary creatinine excretion 
*Percentage of completion of the follow-up; †FFQ: Food Frequency Questionnaire; ‡Values in mmol/day.  
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Table S2. Newcastle - Ottawa quality assessment scale for included studies (A), with details 
of score assignment with number of stars in parenthesis (B). 
 
(A) Newcastle - Ottawa quality assessment scale 
Selection 
1) Representativeness of the exposed cohort  
a) truly representative of the average adult 
population in the community* 
b) somewhat representative of the average adult 
population in the community 
c) selected group of users eg nurses, volunteers 
d) no description of the derivation of the cohort  
2) Selection of the non exposed cohort 
a) drawn from the same community as the exposed 
cohort* 
b) drawn from a different source 
c) no description of the derivation of the non 
exposed cohort   
3) Ascertainment of exposure 
a) secure record (e.g, surgical records)* 
b) structured interview* 
c) written self report 
d) no description   
4) Demonstration that outcome of interest was not present 
at start of study 
a) yes 
b) no   
Comparability  
1) Comparability of cohorts on the basis of the design 
or analysis 
a) study controls for age* 
b) study controls for smoking status* 
Outcome  
1) Assessment of outcome 
a) independent blind assessment* 
b) record linkage* 
c) self report 
d) no description  
2) Was follow-up long enough for outcomes to occur 
a) yes (10 years follow up period has 
considered adequate)* 
b) no   
3) Adequacy of follow up of cohorts 
a) complete follow up accounted for 100% of 
subjects* 
b) subjects lost to follow up unlikely to 
introduce bias – lost at follow-up ≤5%* 
c) follow up rate <95% and no description of 
those lost 
d) no statement 
(B) Details of score assignment 
Reference 
Selection Comparability Outcome Total 
S-1 S-2 S-3 S-4 C-1 C-2 O-1 O-2 O-3 Score 
Khaw 19871 c (0) a (1) b (1) a (1) a (1) a (1) b (1) a (1) a (1) 8 
Lee 19882 c (0) a (1) c (0) a (1) a (1) b (0) c (0) a (1) b (0) 4 
Bazzano 20013 a (1) a (1) b (1) a (1) a (1) a (1) b (1) a (1) a (1) 9 
Green 20024 a (1) a (1) c (0) a (1) a (1) b (0) b (1) a (1) a (1) 7 
Gelejinse 20075 b (0) a (1) a (1) b (0) a (1) a (1) b (1) b (0) d (0) 5 
Larsson 20086 c (0) a (1) c (0) a (1) a (1) a (1) b (1) a (1) a (1) 7 
Umesawa 20087 a (1) a (1) c (0) a (1) a (1) a (1) a (1) a (1) a (1) 8 
Weng 20088 b (0) a (1) c (0) a (1) a (1) a (1) b (1) a (1) a (1) 7 
Larsson 20119 b (0) a (1) c (0) a (1) a (1) a (1) b (1) a (1) a (1) 7 
O’Donnell 201110 c (0) a (1) a (1) b (0) a (1) a (1) a (1) b (0) a (1) 6 
O’Donnell 201411 b (0) a (1) a (1) a (1) a (1) a (1) c (0) b (0) a (1) 6 
Seth 201412 a (1) a (1) c (0) a (1) a (1) a (1) c (0) a (1) a (1) 7 
Slujis 201413 b (0) a (1) c (0) b (0) a (1) a (1) b (1) a (1) d (0) 5 
Adebamowo 2015a14 c (0) a (1) c (0) a (1) a (1) a (1) c (0) a (1) b (0) 5 
Adebamowo 2015b15 c (0) a (1) c (0) a (1) a (1) a (1) c (0) a (1) b (0) 5 
Kieneker 201616 b (0) a (1) a (1) a (1) a (1) a (1) b (1) a (1) b (0) 7 		
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Figure S1. 
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Figure S2.  
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Figure S3.  
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Figure S4.  
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Figure S1. Meta-analysis of the relative risk (RR, with 95% confidence interval (CI)) of 
stroke in observational cohort studies according to categories of baseline dietary potassium 
intake (<90, ≥90 to <120, ≥120 mmol/day) restricted to studies reporting both blood pressure-
adjusted and unadjusted estimates.6, 7, 9, 10, 12, 14, 15 
 
Figure S2. Meta-analysis of the relative risk (RR, with 95% confidence interval (CI)) of 
stroke in observational cohort studies according to stroke outcome (mortality or incidence). 
Estimates are from the ‘most adjusted model’ (A) and from the ‘blood pressure unadjusted 
model’ (B).1-17 
 
Figure S3. Meta-analysis of the relative risk (RR, with 95% confidence interval (CI)) of 
stroke in observational cohort studies according to sex of study participants. Estimates are 
from the ‘most adjusted model’ (A), from the ‘blood pressure unadjusted model’ (B) and 
from studies using both methods (C).1, 2, 6, 9, 12, 14, 15 
 
Figure S4. Pooled dose-response association between potassium intake and risk of stroke 
(solid line) in a meta-analysis modeling potassium intake with restricted cubic splines in a 
multivariate random-effects model, according to stroke subtype: ischemic type with (A) and 
without (B) for blood pressure adjustment, and haemorrhagic subtype with (C) and without 
(D) blood pressure adjustment. Dashed lines represent the 95% confidence intervals for the 
spline model. 
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